AC Immune S.A.ACIUNASDAQ
Loading
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 16.62% |
| Q2 2025 | -0.09% |
| Q1 2025 | -4.04% |
| Q4 2024 | -356.13% |
| Q3 2024 | 134.68% |
| Q2 2024 | -4.45% |
| Q1 2024 | -466.73% |
| Q4 2023 | 77.10% |
| Q3 2023 | 9.27% |
| Q2 2023 | 2.99% |
| Q1 2023 | 6.02% |
| Q4 2022 | -38.88% |
| Q3 2022 | 32.21% |
| Q2 2022 | -5.46% |
| Q1 2022 | 17.37% |
| Q4 2021 | -12.35% |
| Q3 2021 | -8.53% |
| Q2 2021 | -8.34% |
| Q1 2021 | 11.37% |
| Q4 2020 | -3.51% |
| Q3 2020 | -219.88% |
| Q2 2020 | 314.83% |
| Q1 2020 | 61.21% |
| Q4 2019 | -204.71% |
| Q3 2019 | 221.68% |
| Q2 2019 | -124.56% |
| Q1 2019 | 515.21% |
| Q4 2018 | -19.04% |
| Q3 2018 | -5.19% |
| Q2 2018 | -2.19% |
| Q1 2018 | -455.14% |
| Q4 2017 | 133.07% |
| Q3 2017 | -16.81% |
| Q2 2017 | -5.35% |
| Q1 2017 | 13.55% |
| Q4 2016 | -12.21% |
| Q3 2016 | -164.78% |
| Q2 2016 | 315.54% |
| Q1 2016 | 8.28% |
| Q4 2015 | -132.63% |